These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Association of Qian J; Betensky RA; Hyman BT; Serrano-Pozo A Neurology; 2021 May; 96(19):e2414-e2428. PubMed ID: 33771840 [TBL] [Abstract][Full Text] [Related]
3. Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis. Agarwal R; Tripathi CB Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):575-82. PubMed ID: 25551132 [TBL] [Abstract][Full Text] [Related]
4. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. Farrer LA; Cupples LA; Haines JL; Hyman B; Kukull WA; Mayeux R; Myers RH; Pericak-Vance MA; Risch N; van Duijn CM JAMA; 1997 Oct 22-29; 278(16):1349-56. PubMed ID: 9343467 [TBL] [Abstract][Full Text] [Related]
5. Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis. Chen Q; Wang T; Kang D; Chen L Sci Rep; 2022 Aug; 12(1):13620. PubMed ID: 35948759 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E polymorphism and age of onset for Alzheimer's disease in a bi-ethnic sample. Harwood DG; Barker WW; Ownby RL; St George-Hyslop P; Mullan M; Duara R Int Psychogeriatr; 2004 Sep; 16(3):317-26. PubMed ID: 15559755 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex. Bickeböller H; Campion D; Brice A; Amouyel P; Hannequin D; Didierjean O; Penet C; Martin C; Pérez-Tur J; Michon A; Dubois B; Ledoze F; Thomas-Anterion C; Pasquier F; Puel M; Demonet JF; Moreaud O; Babron MC; Meulien D; Guez D; Chartier-Harlin MC; Frebourg T; Agid Y; Martinez M; Clerget-Darpoux F Am J Hum Genet; 1997 Feb; 60(2):439-46. PubMed ID: 9012418 [TBL] [Abstract][Full Text] [Related]
8. Increased CSF cortisol in AD is a function of APOE genotype. Peskind ER; Wilkinson CW; Petrie EC; Schellenberg GD; Raskind MA Neurology; 2001 Apr; 56(8):1094-8. PubMed ID: 11320185 [TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492 [TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals. Pettigrew C; Nazarovs J; Soldan A; Singh V; Wang J; Hohman T; Dumitrescu L; Libby J; Kunkle B; Gross AL; Johnson S; Lu Q; Engelman C; Masters CL; Maruff P; Laws SM; Morris JC; Hassenstab J; Cruchaga C; Resnick SM; Kitner-Triolo MH; An Y; Albert M Alzheimers Res Ther; 2023 Mar; 15(1):66. PubMed ID: 36978190 [TBL] [Abstract][Full Text] [Related]
11. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease. Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O; JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367 [TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E gene in physiological and pathological aging. Ferri E; Gussago C; Casati M; Mari D; Rossi PD; Ciccone S; Cesari M; Arosio B Mech Ageing Dev; 2019 Mar; 178():41-45. PubMed ID: 30658061 [TBL] [Abstract][Full Text] [Related]
14. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging. Klages JD; Fisk JD; Rockwood K Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E polymorphisms in adults over 60 years of age with mild cognitive impairment and Alzheimer’s disease in different Venezuelan populations. Martínez S; Ochoa B; Pérez MR; Torrico F; García I; Garcia CC Biomedica; 2022 May; 42(Sp. 1):116-129. PubMed ID: 35866735 [TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E Genotypes, Age, Race, and Cognitive Decline in a Population Sample. Rajan KB; Barnes LL; Wilson RS; Weuve J; McAninch EA; Evans DA J Am Geriatr Soc; 2019 Apr; 67(4):734-740. PubMed ID: 30584655 [TBL] [Abstract][Full Text] [Related]
17. Risk of Alzheimer disease with the epsilon4 allele for apolipoprotein E in a population-based study of men aged 62-73 years. Breitner JC; Jarvik GP; Plassman BL; Saunders AM; Welsh KA Alzheimer Dis Assoc Disord; 1998 Mar; 12(1):40-4. PubMed ID: 9539409 [TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. Myers RH; Schaefer EJ; Wilson PW; D'Agostino R; Ordovas JM; Espino A; Au R; White RF; Knoefel JE; Cobb JL; McNulty KA; Beiser A; Wolf PA Neurology; 1996 Mar; 46(3):673-7. PubMed ID: 8618665 [TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E polymorphism in elderly Chilean people with Alzheimer's disease. Quiroga P; Calvo C; Albala C; Urquidi J; Santos JL; Pérez H; Klaassen G Neuroepidemiology; 1999; 18(1):48-52. PubMed ID: 9831815 [TBL] [Abstract][Full Text] [Related]
20. Transcriptomic Downregulation of APOE, Polymorphic Variations of APOE, Diet, Social Isolation, and Co-morbidities as Contributing Factors to Alzheimer's Disease: a Case-Control Study of Kashmiri Population. Nissar K; Firdous P; Hussain A; Bashir S; Ahmad Z; Ganai BA Mol Neurobiol; 2023 Oct; 60(10):5891-5901. PubMed ID: 37357229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]